Debt-to-equity in % of Gossamer Bio, Inc. from Q3 2019 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Gossamer Bio, Inc. quarterly Debt-to-equity history and change rate from Q3 2019 to Q3 2025.
  • Gossamer Bio, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -1.09K %, a 330% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Gossamer Bio, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -1.09K -1.57K -330% 30 Sep 2025
Q2 2025 3.7K +3.33K +902% 30 Jun 2025
Q1 2025 731 -7.64 -1.04% 31 Mar 2025
Q4 2024 577 -717 -55.4% 31 Dec 2024
Q3 2024 475 -3.44K -87.9% 30 Sep 2024
Q2 2024 369 +4.84K 30 Jun 2024
Q1 2024 738 -3.68K -83.3% 31 Mar 2024
Q4 2023 1.29K +10.5 +0.81% 31 Dec 2023
Q3 2023 3.92K +3.39K +638% 30 Sep 2023
Q2 2023 -4.47K -4.79K -1511% 30 Jun 2023
Q1 2023 4.42K +4.25K +2514% 31 Mar 2023
Q4 2022 1.28K +1.17K +1068% 31 Dec 2022
Q3 2022 531 +443 +508% 30 Sep 2022
Q2 2022 317 +245 +340% 30 Jun 2022
Q1 2022 169 +108 +177% 31 Mar 2022
Q4 2021 110 +60.5 +123% 31 Dec 2021
Q3 2021 87.3 +49 +128% 30 Sep 2021
Q2 2021 72 +43.9 +156% 30 Jun 2021
Q1 2021 61.1 +42.7 +232% 31 Mar 2021
Q4 2020 49.4 +34.6 +235% 31 Dec 2020
Q3 2020 38.3 +22.2 +138% 30 Sep 2020
Q2 2020 28.1 30 Jun 2020
Q1 2020 18.4 31 Mar 2020
Q4 2019 14.7 31 Dec 2019
Q3 2019 16.1 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.